J&J Keeps Expectations Conservative For OTC Manufacturing Remediation
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson expects the resumption of manufacturing the children's OTC drugs the firm's McNeil Consumer Healthcare business recalled this year may be as far off as April 2011
You may also be interested in...
J&J/McNeil Done With Post-Recall Personnel Changes - CEO Weldon
Johnson & Johnson has finished culling its ranks of employees responsible for quality control lapses that led to extensive OTC recalls, according to CEO William Weldon.
J&J/McNeil Done With Post-Recall Personnel Changes - CEO Weldon
Johnson & Johnson has finished culling its ranks of employees responsible for quality control lapses that led to extensive OTC recalls, according to CEO William Weldon.
J&J/McNeil Done With Post-Recall Personnel Changes - CEO Weldon
Johnson & Johnson has finished culling its ranks of employees responsible for quality control lapses that led to extensive OTC recalls, according to CEO William Weldon.